Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: A randomised, quadruple-blind, sham controlled trial (LASER-1).

Nijenhuis-Rosien L, Kleefstra N, van Dijk PR, Wolfhagen MJHM, Groenier KH, Bilo HJG, Landman GWD.

J Eur Acad Dermatol Venereol. 2019 Mar 28. doi: 10.1111/jdv.15601. [Epub ahead of print]

PMID:
30920059
2.

Serum free thiols in type 2 diabetes mellitus: A prospective study.

Schillern EEM, Pasch A, Feelisch M, Waanders F, Hendriks SH, Mencke R, Harms G, Groenier KH, Bilo HJG, Hillebrands JL, van Goor H, van Dijk PR.

J Clin Transl Endocrinol. 2019 Feb 28;16:100182. doi: 10.1016/j.jcte.2019.100182. eCollection 2019 Jun.

3.

Correction to: Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy.

Spaans E, van Hateren KJJ, Groenier KH, Bilo HJG, Kleefstra N, Brand PLP.

Eur J Pediatr. 2019 Apr;178(4):605-606. doi: 10.1007/s00431-019-03325-8.

PMID:
30684008
4.

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.

Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M; CKD Prognosis Consortium (CKD-PC).

BMJ. 2019 Jan 10;364:k5301. doi: 10.1136/bmj.k5301.

5.

Repeat whole blood donors with a ferritin level of 30 μg/L or less show functional iron depletion.

Dijkstra A, van den Hurk K, Bilo HJG, Slingerland RJ, Vos MJ.

Transfusion. 2019 Jan;59(1):21-25. doi: 10.1111/trf.14935. Epub 2018 Oct 6.

PMID:
30291758
6.

Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy.

Spaans E, van Hateren KJJ, Groenier KH, Bilo HJG, Kleefstra N, Brand PLP.

Eur J Pediatr. 2018 Dec;177(12):1831-1836. doi: 10.1007/s00431-018-3256-1. Epub 2018 Sep 20. Erratum in: Eur J Pediatr. 2019 Jan 25;:.

PMID:
30238153
7.

Is guideline-adherent prescribing associated with quality of life in patients with type 2 diabetes?

Smits KPJ, Sidorenkov G, Kleefstra N, Hendriks SH, Bouma M, Meulepas M, Navis G, Bilo HJG, Denig P.

PLoS One. 2018 Aug 16;13(8):e0202319. doi: 10.1371/journal.pone.0202319. eCollection 2018.

8.

Diagnosing orthostatic hypotension with continuous and interval blood pressure measurement devices.

Breeuwsma AC, Hartog LC, Kamper AM, Groenier KH, Bilo HJG, Kleefstra N, Van Hateren KJJ.

J Hum Hypertens. 2018 Dec;32(12):831-837. doi: 10.1038/s41371-018-0091-9. Epub 2018 Aug 14.

PMID:
30108291
9.

Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52).

Hendriks SH, Blanker MH, Roelofsen Y, van Hateren KJJ, Groenier KH, Bilo HJG, Kleefstra N.

BMC Health Serv Res. 2018 Apr 10;18(1):266. doi: 10.1186/s12913-018-3086-x.

10.

Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56).

Hendriks SH, Schrijnders D, van Hateren KJ, Groenier KH, Siesling S, Maas AHEM, Landman GWD, Bilo HJG, Kleefstra N.

BMJ Open. 2018 Jan 24;8(1):e018859. doi: 10.1136/bmjopen-2017-018859.

11.

Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49).

Schrijnders D, Hendriks SH, Kleefstra N, Vissers PAJ, Johnson JA, de Bock GH, Bilo HJG, Landman GWD.

PLoS One. 2018 Jan 25;13(1):e0190870. doi: 10.1371/journal.pone.0190870. eCollection 2018.

12.

Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial.

Hortensius J, Kleefstra N, Landman GWD, Houweling BT, Groenier KH, van der Bijl JJ, Bilo H.

BMC Res Notes. 2018 Jan 15;11(1):26. doi: 10.1186/s13104-018-3138-7.

13.

A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes.

Hertroijs DFL, Elissen AMJ, Brouwers MCGJ, Schaper NC, Köhler S, Popa MC, Asteriadis S, Hendriks SH, Bilo HJ, Ruwaard D.

Diabetes Obes Metab. 2018 Mar;20(3):681-688. doi: 10.1111/dom.13148. Epub 2017 Nov 24.

14.

Sex differences in survival of patients with type 2 diabetes in primary care (ZODIAC-50).

Hendriks SH, van Hateren KJJ, Groenier KH, Landman GWD, Maas AHEM, Bilo HJG, Kleefstra N.

BMJ Open. 2017 Oct 25;7(10):e015870. doi: 10.1136/bmjopen-2017-015870.

15.

Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial.

van den Dries CJ, Oudega R, Elvan A, Rutten FH, van de Leur SJCM, Bilo HJG, Hoes AW, Moons KGM, Geersing GJ.

BMJ Open. 2017 Sep 18;7(9):e015510. doi: 10.1136/bmjopen-2016-015510.

16.

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol.

Schrijnders D, de Bock GH, Houweling ST, van Hateren KJJ, Groenier KH, Johnson JA, Bilo HJG, Kleefstra N, Landman GWD.

BMC Cancer. 2017 Jun 23;17(1):444. doi: 10.1186/s12885-017-3433-z.

17.

Thyroid Disease and Type 1 Diabetes in Dutch Children: A Nationwide Study (Young Dudes-3).

Spaans E, Schroor E, Groenier K, Bilo H, Kleefstra N, Brand P.

J Pediatr. 2017 Aug;187:189-193.e1. doi: 10.1016/j.jpeds.2017.05.016. Epub 2017 Jun 2.

PMID:
28583704
18.

Prescribing Quality and Prediction of Clinical Outcomes in Patients With Type 2 Diabetes: A Prospective Cohort Study.

Smits KPJ, Sidorenkov G, Navis G, Bouma M, Meulepas MA, Bilo HJG, Denig P.

Diabetes Care. 2017 Jul;40(7):e83-e84. doi: 10.2337/dc17-0236. Epub 2017 May 4. No abstract available.

PMID:
28473336
19.

Is orthostatic hypotension related to falling? A meta-analysis of individual patient data of prospective observational studies.

Hartog LC, Schrijnders D, Landman GWD, Groenier K, Kleefstra N, Bilo HJG, van Hateren KJJ.

Age Ageing. 2017 Jul 1;46(4):568-575. doi: 10.1093/ageing/afx024. Review.

20.

Lifestyle and emotional well-being in men and women with type 2 diabetes (e-VitaDM-4; ZODIAC-48).

Hendriks SH, van Soldt EG, van Vugt M, Groenier KH, Roelofsen Y, Maas AH, Bilo HJ, Kleefstra N, van Hateren KJ.

Eur J Gen Pract. 2017 Dec;23(1):83-90. doi: 10.1080/13814788.2017.1292348.

21.

Standing orthostatic blood pressure measurements cannot be replaced by sitting measurements.

Breeuwsma AC, Hartog LC, Kamper AM, Groenier KH, Bilo HJ, Kleefstra N, Van Hateren KJ.

Hypertens Res. 2017 Aug;40(8):765-770. doi: 10.1038/hr.2017.39. Epub 2017 Mar 16.

PMID:
28298654
22.

The clinical relevance of orthostatic hypotension in elderly patients.

Hartog L, Kleefstra N, Luigies R, de Rooij S, Bilo H, van Hateren K.

Geriatr Gerontol Int. 2017 Nov;17(11):1881-1885. doi: 10.1111/ggi.12983. Epub 2017 Feb 22.

PMID:
28224694
23.

Whole Blood Donation Affects the Interpretation of Hemoglobin A1c.

Dijkstra A, Lenters-Westra E, de Kort W, Bokhorst AG, Bilo HJ, Slingerland RJ, Vos MJ.

PLoS One. 2017 Jan 24;12(1):e0170802. doi: 10.1371/journal.pone.0170802. eCollection 2017.

24.

Development and validation of prescribing quality indicators for patients with type 2 diabetes.

Smits KP, Sidorenkov G, Kleefstra N, Bouma M, Meulepas M, Voorham J, Navis G, Bilo HJ, Denig P.

Int J Clin Pract. 2017 Jan;71(1). doi: 10.1111/ijcp.12922. Epub 2016 Dec 16.

PMID:
27981681
25.

Hypoglycemia in Frail Elderly Patients With Type 2 Diabetes Mellitus Treated With Sulfonylurea.

van Dijk P, Bouma A, Landman GW, Groenier KH, Bilo H, Kleefstra N, van Hateren KJ.

J Diabetes Sci Technol. 2017 Mar;11(2):438-439. doi: 10.1177/1932296816668873. Epub 2016 Sep 25. No abstract available.

26.

Development and initial validation of prescribing quality indicators for patients with chronic kidney disease.

Smits KP, Sidorenkov G, Bilo HJ, Bouma M, van Ittersum FJ, Voorham J, Navis G, Denig P.

Nephrol Dial Transplant. 2016 Nov;31(11):1876-1886. Epub 2016 Jan 6.

PMID:
26743176
27.

Process quality indicators for chronic kidney disease risk management: a systematic literature review.

Smits KP, Sidorenkov G, Bilo HJ, Bouma M, Navis GJ, Denig P.

Int J Clin Pract. 2016 Oct;70(10):861-869. doi: 10.1111/ijcp.12878. Epub 2016 Sep 19. Review.

PMID:
27640992
28.

Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women?

Hendriks SH, Hartog LC, Groenier KH, Maas AH, van Hateren KJ, Kleefstra N, Bilo HJ.

J Diabetes Res. 2016;2016:7386532. Epub 2016 Aug 30.

29.

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43).

Schrijnders D, Hartog LC, Kleefstra N, Groenier KH, Landman GW, Bilo HJ.

PLoS One. 2016 Jun 21;11(6):e0157668. doi: 10.1371/journal.pone.0157668. eCollection 2016.

30.

Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC-39).

Schrijnders D, Wever R, Kleefstra N, Houweling ST, van Hateren KJ, de Bock GH, Bilo HJ, Groenier KH, Landman GW.

Diabetes Obes Metab. 2016 Oct;18(10):973-9. doi: 10.1111/dom.12700. Epub 2016 Jul 13.

31.

Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).

Landman GW, Kleefstra N, Groenier KH, Bakker SJ, Groeneveld GH, Bilo HJ, van Hateren KJ.

Atherosclerosis. 2016 Jul;250:46-51. doi: 10.1016/j.atherosclerosis.2016.04.015. Epub 2016 Apr 27.

PMID:
27179179
32.

Different Effects of Intraperitoneal and Subcutaneous Insulin Administration on the GH-IGF-1 Axis in Type 1 Diabetes.

van Dijk PR, Logtenberg SJ, Chisalita SI, Hedman CA, Groenier KH, Gans RO, Kleefstra N, Arnqvist HJ, Bilo HJ.

J Clin Endocrinol Metab. 2016 Jun;101(6):2493-501. doi: 10.1210/jc.2016-1473. Epub 2016 Apr 26.

PMID:
27115061
33.

Orthostatic changes in blood pressure and mortality in a nursing home population.

Hartog LC, Hendriks SH, Cimzar-Sweelssen M, Knipscheer A, Groenier KH, Kleefstra N, Bilo HJ, van Hateren KJ.

J Hypertens. 2016 Jun;34(6):1068-74. doi: 10.1097/HJH.0000000000000910.

PMID:
27032073
34.

Seasonality of diagnosis of type 1 diabetes mellitus in the Netherlands (Young Dudes-2).

Spaans EA, van Dijk PR, Groenier KH, Brand PL, Reeser MH, Bilo HJ, Kleefstra N.

J Pediatr Endocrinol Metab. 2016 Jun 1;29(6):657-61. doi: 10.1515/jpem-2015-0435.

PMID:
27008693
35.

High-sensitive troponin T is associated with all-cause and cardiovascular mortality in stable outpatients with type 2 diabetes (ZODIAC-37).

Hendriks SH, van Dijk PR, van Hateren KJ, van Pelt JL, Groenier KH, Bilo HJ, Bakker SJ, Landman GW, Kleefstra N.

Am Heart J. 2016 Apr;174:43-50. doi: 10.1016/j.ahj.2015.12.015. Epub 2015 Dec 31.

PMID:
26995369
36.

Validity of an Accelerometer-Based Activity Monitor System for Measuring Physical Activity in Frail Older Adults.

Hollewand AM, Spijkerman AG, Bilo HJ, Kleefstra N, Kamsma Y, van Hateren KJ.

J Aging Phys Act. 2016 Oct;24(4):555-558. Epub 2016 Aug 24.

PMID:
26964560
37.

Sex Differences in the Quality of Diabetes Care in the Netherlands (ZODIAC-45).

Hendriks SH, van Hateren KJ, Groenier KH, Houweling ST, Maas AH, Kleefstra N, Bilo HJ.

PLoS One. 2015 Dec 29;10(12):e0145907. doi: 10.1371/journal.pone.0145907. eCollection 2015.

38.

Effects of a lifestyle program in subjects with Impaired Fasting Glucose, a pragmatic cluster-randomized controlled trial.

Hesselink AE, Rutten GE, Slootmaker SM, de Weerdt I, Raaijmakers LG, Jonkers R, Martens MK, Bilo HJ.

BMC Fam Pract. 2015 Dec 22;16:183. doi: 10.1186/s12875-015-0394-7.

39.

Dutch diabetes prevalence estimates (DUDE-1).

Kleefstra N, Landman GW, Van Hateren KJ, Meulepas M, Romeijnders A, Rutten GE, Klomp M, Houweling ST, Bilo HJ.

J Diabetes. 2016 Nov;8(6):863-865. doi: 10.1111/1753-0407.12370. Epub 2016 Mar 23.

PMID:
26694523
40.

Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44).

Roelofsen Y, van Vugt M, Hendriks SH, van Hateren KJ, Groenier KH, Snoek FJ, Kleefstra N, Huijsman R, Bilo HJ.

J Diabetes Res. 2016;2016:6343927. doi: 10.1155/2016/6343927. Epub 2015 Nov 22.

41.

Validation of the howRu and howRwe questionnaires at the individual patient level.

Hendriks SH, Rutgers J, van Dijk PR, Groenier KH, Bilo HJ, Kleefstra N, Kocks JW, van Hateren KJ, Blanker MH.

BMC Health Serv Res. 2015 Oct 2;15:447. doi: 10.1186/s12913-015-1093-8.

42.

After 6years of intraperitoneal insulin administration IGF-I concentrations in T1DM patients are at low-normal level.

van Dijk PR, Logtenberg SJ, Chisalita SI, Hedman CA, Groenier KH, Gans RO, Kleefstra N, Arnqvist HJ, Bilo HJ.

Growth Horm IGF Res. 2015 Dec;25(6):316-9. doi: 10.1016/j.ghir.2015.08.007. Epub 2015 Aug 28.

PMID:
26336814
43.

Limited joint mobility syndrome in diabetes mellitus: A minireview.

Gerrits EG, Landman GW, Nijenhuis-Rosien L, Bilo HJ.

World J Diabetes. 2015 Aug 10;6(9):1108-12. doi: 10.4239/wjd.v6.i9.1108. Review.

44.

Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32).

van Hateren KJ, Landman GW, Arnold JF, Joosten H, Groenier KH, Navis GJ, Sparwasser A, Bakker SJ, Bilo HJ, Kleefstra N.

PLoS One. 2015 Jul 28;10(7):e0133065. doi: 10.1371/journal.pone.0133065. eCollection 2015.

45.

Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46).

Riphagen IJ, Logtenberg SJ, Groenier KH, van Hateren KJ, Landman GW, Struck J, Navis G, Kootstra-Ros JE, Kema IP, Bilo HJ, Kleefstra N, Bakker SJ.

Atherosclerosis. 2015 Sep;242(1):179-85. doi: 10.1016/j.atherosclerosis.2015.07.010. Epub 2015 Jul 8.

PMID:
26201002
46.

Familial Aggregation between the 14th and 21st Century and Type 2 Diabetes Risk in an Isolated Dutch Population.

de Visser KL, Landman GW, Kleefstra N, Meyboom-de Jong B, de Visser W, te Meerman GJ, Bilo HJ.

PLoS One. 2015 Jul 20;10(7):e0132549. doi: 10.1371/journal.pone.0132549. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0137939. Kleefstra, Nanne [added].

47.

Alanine aminotransferase and mortality in patients with type 2 diabetes (ZODIAC-38).

Deetman PE, Alkhalaf A, Landman GW, Groenier KH, Kootstra-Ros JE, Navis G, Bilo HJ, Kleefstra N, Bakker SJ.

Eur J Clin Invest. 2015 Aug;45(8):807-14. doi: 10.1111/eci.12474. Epub 2015 Jul 3.

PMID:
26046667
48.

A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.

Pena MJ, Heinzel A, Heinze G, Alkhalaf A, Bakker SJ, Nguyen TQ, Goldschmeding R, Bilo HJ, Perco P, Mayer B, de Zeeuw D, Lambers Heerspink HJ.

PLoS One. 2015 May 14;10(5):e0120995. doi: 10.1371/journal.pone.0120995. eCollection 2015.

49.

The Effects of a Mobile Phone Application on Quality of Life in Patients With Type 1 Diabetes Mellitus: A Randomized Controlled Trial.

Drion I, Pameijer LR, van Dijk PR, Groenier KH, Kleefstra N, Bilo HJ.

J Diabetes Sci Technol. 2015 May 11;9(5):1086-91. doi: 10.1177/1932296815585871.

50.

Frailty and the relationship between blood pressure and mortality in elderly patients with type 2 diabetes (Zwolle Outpatient Diabetes project Integrating Available Care-34).

van Hateren KJ, Hendriks SH, Groenier KH, Bakker SJ, Bilo HJ, Kleefstra N, Landman GW.

J Hypertens. 2015 Jun;33(6):1162-6. doi: 10.1097/HJH.0000000000000555.

PMID:
25923730

Supplemental Content

Loading ...
Support Center